ghk-cu injection adverse events case report Frontiers GHK-Cu Copper Peptide for Anti-Aging
Description
The further synergistic combination approach with other gastrointestinal hormones and creation of dual GIP/GLP-1 receptor agonists, such as tirzepatide and GLP-1/GIP/glucagon receptor triagonist, retatrutide, has shown unprecedented pharmacologically achieved weight loss with further cardiometabolic benefits in both obesity and T2DM

Ehrich, E., Turncliff, R., Du, Y., Leigh-Pemberton, R., Fernandez, E., Jones, R., & Fava, M

Most of the time, the issue is either incorrect dosing, a protocol not matched to their specific labs, or a compound thats not the right fit for their goals
Likewise, in the context of Alzheimers disease, reduced MFN2 and mitochondrial fission factor abundance have been linked to aberrant mitochondrial morphology and function, accompanied by increased HDAC2 activity and miR-195 expression [28]
